Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2007
03/15/2007WO2007028999A1 Thiazole compounds and their use as pgd2 antagonists
03/15/2007US20070060647 Gene expression regulating agent
03/15/2007US20070060619 Nicotinamide-based kinase inhibitors
03/15/2007US20070060591 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections
03/15/2007US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases
03/15/2007US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction
03/15/2007US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors
03/15/2007US20070060568 5HT2c receptor modulators
03/15/2007US20070060563 Quinuclidine derivatives binding to mucarinic m3 receptors
03/15/2007US20070060553 3-Nitrogen-6,7-dioxygen steroids and uses related thereto
03/15/2007US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
03/15/2007US20070059756 Immunointeractive molecules and their uses in treating subjects suffering from Hev b 5 allergies
03/15/2007US20070059328 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthma (obstructive lung disease)
03/15/2007US20070059290 Transcriptional regulation of target genes
03/15/2007DE102005042768A1 Magnetfeld-gesteuerter Wirkstofftransfer für die Aerosoltherapie Magnetic field controlled drug transfer for aerosol therapy
03/15/2007CA2622016A1 Interferon lambda therapy for treatment of respiratory diseases
03/15/2007CA2621470A1 Bicyclic aromatic substituted pyridone derivative
03/15/2007CA2621187A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases
03/14/2007EP1762610A1 Truncated dance, dance complex and method of using these
03/14/2007EP1762557A2 Aspirin-triggered lipid mediators
03/14/2007EP1761526A2 Thiazole derivatives as chemokine receptor antagonists
03/14/2007EP1761509A2 Substituted cycloalkyl derivatives for the treatment of respiratory diseases
03/14/2007EP1761494A1 Chemical compounds i
03/14/2007EP1761280A1 Combinations comprising antimuscarinic agents and pde4 inhibitors
03/14/2007EP1761279A1 Combinations comprising antimuscarinic agents and pde4 inhibitors
03/14/2007EP1761256A1 Cla-enriched milkfat and uses thereof
03/14/2007EP1487842B1 An optically acitve pyridine derivative and a medicament containing the same
03/14/2007EP1406897B1 Compounds
03/14/2007EP1163226B1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
03/14/2007EP1011637B1 Modulation of drug loading in multivesicular liposomes
03/14/2007CN1930163A Novel dichloro-phenyl-pyrido [2,3-d] pyrimidine derivates, their manufacture and use as pharmaceutical agents
03/14/2007CN1930162A Tetrahydropyridoindole derivatives
03/14/2007CN1930158A New quaternized quinuclidine esters
03/14/2007CN1930126A 吡啶酮衍生物 Pyridine derivatives
03/14/2007CN1929833A Oxydecahydronaphthalene modulators of HM74
03/14/2007CN1929824A Soft gelatin capsule comprising omega-3-polyunsaturated fatty acid
03/14/2007CN1928076A Live vaccine for mycoplasma pneumonia of swine and production method thereof
03/14/2007CN1927854A Preparation method of potassium sodium dehydroandroan drographolide succinate, potassium sodium dehydroandroan drographolide succinate preparation and preparation method thereof
03/14/2007CN1927405A Combination immunizing preparation comprising recombinant plasmid and duplicate deficit type recombinant adenovirus
03/14/2007CN1927379A Traditional medicine preparation for treating children's pulmonary disease
03/14/2007CN1927352A Externally used traditional Chinese medicine preparation for treating nasal mucosa erosion and nosebleed and its preparation method
03/14/2007CN1927342A Heat clearing and detoxicating dispersant tablet and method for making same
03/14/2007CN1927340A Medicine for treating infantile pneumonia
03/14/2007CN1927338A Traditional Chinese medicine composition for treating respiratory tract system inflammation
03/14/2007CN1927337A Preparation process of medicine for treating cough and asthma
03/14/2007CN1927313A Pharmaceutical composition for treating pharyngitis
03/14/2007CN1927303A Chinese medicine for treating chicken respiratory tract disease
03/14/2007CN1927278A Children's Shuangqing dispersant tablet and method for making same
03/14/2007CN1927275A Medicament for animals with heat clearing, diuresis, phlegm removing and detoxicating functions and preparing method thereof
03/14/2007CN1927273A Bath agent for influenza defervesce and preparing method thereof
03/14/2007CN1927272A Medicament for animals with heat clearing and detoxicating, detumescence and obstruction removing functions and preparing method thereof
03/14/2007CN1927268A Medicine preparation for treating oral cavity and larynx disease
03/14/2007CN1927267A Medicament for animals with heat clearing and dampness eliminating, blood cooling, pathogenic fire purging and detoxifying functions and preparing method thereof
03/14/2007CN1927258A Medicament for animals with heat clearing and dampness eliminating, blood cooling, parasiticide and accumulation removing functions and preparing method thereof
03/14/2007CN1927252A Watermelon frost throat-moistening droplet and its preparation method
03/14/2007CN1927239A Medicament for animals with heat clearing and detoxicating, blood cooling and sore-throat relieving functions and preparing method thereof
03/14/2007CN1927207A Liposome vitamin A acid aerosol for treating chronic obstructive pulmonary disease
03/14/2007CN1304412C Artificial synthesized deoxyoligonucleotide containing CpG single chain and anti single strand linear chain RNA virus
03/14/2007CN1304389C Piperidine derivatives useful as CCR5 antagonists
03/14/2007CN1304383C Benzothiazole derivatives
03/14/2007CN1304382C New p2X* receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
03/14/2007CN1304377C Metalloproteinase inhibitors
03/14/2007CN1304375C Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions
03/14/2007CN1304372C Tri-substituted phenyl derivates useful as PDE IV inhibitors
03/14/2007CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals
03/14/2007CN1304041C Method of PH gradient extracting bamboo juice
03/14/2007CN1304024C Method for preparing extracts of rabdosia effective ingredient
03/14/2007CN1304018C Cough-stopping throat-clearing medicament made from chrysanthemum flower
03/14/2007CN1304012C Glossy ganoderma throat fortifying tablet and its preparation method
03/14/2007CN1304010C Ribavirin inhalation powder atomizing agent and its preparing process
03/14/2007CN1304000C Use of valsartan in preparing drug for treating lung cancer
03/14/2007CN1303995C Use of alpine yarrow herb effective parts in preparing medicine for respiratory tract virus
03/13/2007US7189870 Cardiovascular disorders; antiinflammatory agents
03/13/2007US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology
03/13/2007US7189837 Cell surface molecule-induced macrophage activation
03/13/2007US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases
03/13/2007US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma
03/13/2007US7189756 Pyrrolidine derivatives
03/13/2007US7189751 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis
03/13/2007US7189742 For therapy of disorder associated with elevated levels of 5-HT (5-hydroxytryptamine; serotonin) resultant from newly synthesised 5-HT, anxiety, depression, migraine and sleep apnoea
03/13/2007US7189741 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
03/13/2007US7189739 Antiinflammatory agents; cardiovascular disorders; rheumatic disorders
03/13/2007US7189734 Anilinoquinazaolines as protein tyrosine kianse inhibitors
03/13/2007US7189719 Sodium channel blockers
03/13/2007US7189707 Modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and
03/13/2007US7189525 Human enzymes of the metalloprotease family
03/13/2007US7189404 Strain selection of pneumococcal surface proteins
03/13/2007CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
03/13/2007CA2387533C Purine derivatives
03/13/2007CA2373128C Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application
03/08/2007WO2007027834A1 Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
03/08/2007WO2007027134A1 7-(2-AMINO-1-HYDROXY-ETHYL)-4-HYDROXYBENZOTHIAZOL-2(3H)-ONE-DERIVATIVES AS β2 ADRENOCEPTOR AGONISTS
03/08/2007WO2007027133A1 7-(2-AMINO-1-HYDROXY-ETHYL)-4-HYDROXYBENZOTHIAZOL-2(3H)-ONE-DERIVATIVES AS β2 ADRENOCEPTOR AGONISTS
03/08/2007WO2007026966A1 Thiomorpholine compound and process for preparing the same
03/08/2007WO2007026962A1 Phenylene derivative
03/08/2007WO2007026771A1 Injection for intravenous drip
03/08/2007WO2007026720A1 Ring-fused pyrazole derivative
03/08/2007WO2007026474A1 Nutrient composition
03/08/2007WO2007026358A2 Compositons comprising phosphatidic acid for treatment of eosinophilia and related disorders
03/08/2007WO2007026215A1 Pyrazole derivatives as cannabinoid receptor ligands, pharmaceutical compositions containing? them, and processes for their preparation